GI Symptoms in Infants Fed GMF or CMF

NCT ID: NCT06395571

Last Updated: 2024-05-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-17

Study Completion Date

2019-10-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to assess common gastrointestinal symptoms in healthy Brazilian infants receiving goat milk-based infant formula (GMF) compared to cow's milk-based infant formula (CMF) during a 24 week intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this double-blind, randomized controlled trial, gastrointestinal comfort in infants fed goat milk-based infant formula (GMF) or cow's milk-based infant formula (CMF) was studied.

Fifty-six healthy infants aged 3-12 months were followed for 24 weeks. Stool consistency, regurgitation frequency and crying duration were measured weekly using an adapted version of the Cow's Milk-related Symptom Score (CoMiSSĀ®) where only the items for these scores were used. Blood hemoglobin levels were measured at the start and at the end of the intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Diseases Infant Nutrition Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Double-blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Goat milk-based infant formula

Experimental group receives goat milk-based formula for 24 weeks

Group Type EXPERIMENTAL

Goat milk-based infant formula

Intervention Type DIETARY_SUPPLEMENT

Goat milk-based infant formula fed at age appropriate quantities for 24 weeks

Cow's milk-based infant formula

Control group receives cow's milk-based formula for 24 weeks

Group Type ACTIVE_COMPARATOR

Cow's milk-based infant formula

Intervention Type DIETARY_SUPPLEMENT

Cow's milk-based infant formula formula fed at age appropriate quantities for 24 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Goat milk-based infant formula

Goat milk-based infant formula fed at age appropriate quantities for 24 weeks

Intervention Type DIETARY_SUPPLEMENT

Cow's milk-based infant formula

Cow's milk-based infant formula formula fed at age appropriate quantities for 24 weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* gestational age 37-42 weeks
* 3-12 months old at enrollment
* should have consumed cow's milk-based products during the 48 hours prior to the baseline visit to exclude cow's milk allergic infants

Exclusion Criteria

* metabolic or chronic disease or congenital malformation, serious concurrent illness that would interfere with study treatment, (i.e. sepsis, pneumonia with respiratory failure, cardiac failure)
* infant's parent(s) or primary caregiver(s) diagnosed with major depression
* infant's weight for length at baseline \>\|3\| z-score indexes according to WHO criteria
* infants enrolled in another interventional clinical research study
* infants diagnosed with cow's milk allergies
Minimum Eligible Age

3 Months

Maximum Eligible Age

12 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ausnutria Hyproca B.V.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hugo da Costa Ribeiro, Dr.

Role: PRINCIPAL_INVESTIGATOR

Hospital Professor Edgard Santos, Federal University of Bahia, Salvador, Brazil

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Daycare center

Salvador, Estado de Bahia, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Maximino P, van Lee L, Meijer-Krommenhoek YN, van der Zee L, da Costa Ribeiro Junior H. Common gastrointestinal symptoms in healthy infants receiving goat milk-based formula or cow's milk-based formula: a double-blind, randomized, controlled trial. BMC Pediatr. 2024 Nov 20;24(1):753. doi: 10.1186/s12887-024-05214-y.

Reference Type DERIVED
PMID: 39567910 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P19-009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Goat vs. Cow Milk Digestive Tolerance
NCT07239856 RECRUITING NA